BIOTAGE AB NPV revenue breakdown overview

BIOTAGE AB NPV revenue for the last year amounted to 1.86 B SEK, the most of which — 654.00 M SEK — came from its highest performing source at the moment, Small Molecules & Synthetic Therapeutics, the year earlier bringing 770.00 M SEK. The greatest contribution to the revenue figure was made by North and South America — last year it brought BIOTAGE AB NPV 748.00 M SEK, and the year before that — 660.00 M SEK.